Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX
· Real-Time Price · USD
1.45
0.00 (0.00%)
At close: Jun 17, 2025, 11:44 AM
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|
| Switzerland Revenue | 50.89M | 26.1M | 15.2M |
| Switzerland Revenue Growth | +94.97% | +71.71% | n/a |
| United States Revenue | 2.59M | 14.5M | 116.6M |
| United States Revenue Growth | -82.14% | -87.56% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 7.65M | 6.3M | 6.44M | 8.32M | 8.62M | 8.53M | 7.87M | 8.72M | 8.53M | 7.94M | 7.9M | 7.94M | 8.78M | 7.64M | 6.6M | 6.74M | 5.24M | 4.79M | 4M | 3.37M | 2.18M | 2.02M | 1.25M | 1.03M | 1.08M |
| Selling, General, and Administrative Revenue Growth | +21.44% | -2.22% | -22.52% | -3.49% | +1.01% | +8.44% | -9.76% | +2.23% | +7.43% | +0.44% | -0.43% | -9.58% | +14.92% | +15.81% | -2.15% | +28.72% | +9.29% | +19.92% | +18.51% | +54.47% | +7.86% | +61.92% | +21.12% | -4.09% | n/a |
| Research and Development Revenue | 20.27M | 25.74M | 28.4M | 29.33M | 32.47M | 34.46M | 32.71M | 33.79M | 31.83M | 29.89M | 31.24M | 31.48M | 26.46M | 27.97M | 25.36M | 20.2M | 16.51M | 12.42M | 10.09M | 8.95M | 8.63M | 6.82M | 5.62M | 4.85M | 3.7M |
| Research and Development Revenue Growth | -21.26% | -9.36% | -3.16% | -9.68% | -5.78% | +5.35% | -3.19% | +6.15% | +6.49% | -4.32% | -0.74% | +18.96% | -5.41% | +10.30% | +25.52% | +22.39% | +32.95% | +23.05% | +12.74% | +3.70% | +26.55% | +21.41% | +15.76% | +31.06% | n/a |